Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

À§¾Ï ȯÀÚÀÇ À§ ºÎºÐ ÀýÁ¦¼úÈÄ º¸ÀÌ´Â ´ã°ü È®Àå : À§ ½ÊÀÌÁöÀå ¹®ÇÕ¼ú°ú À§ °øÀå ¹®ÇÕ¼úÀÇ ºñ±³ Bile Duct Dilatation after Subtotal Gastrectomy in Stomach Cancer : Comparison with Gastroduodenostmy (Billoth ¥°) and Gastro Jejunostomy (Billoth ¥±)

´ëÇѹæ»ç¼±ÀÇÇÐȸÁö 1999³â 41±Ç 1È£ p.109 ~ 112
¼Ò¼Ó »ó¼¼Á¤º¸
¿À½Â¿ë/Seung Yong Oh ÀÌÇý°æ/±¸µ¿¾ï/È«Çö¼÷/±Ç±ÍÇâ/Ãֵ渰/¹Ú°æ±Ô/Hae Kyung Lee/Dong Erk Goo/Hyun Sook Hong/Kwi Hyang Kwon/Deuk Lin Choi/Kyung Kyu Park

Abstract

¸ñÀû : À§¾Ï ȯÀÚ¿¡¼­ ¹ÌÁֽŰæ ÀýÁ¦¼úÀ» ¹ÞÁö ¾Ê°í À§ ºÎºÐ ÀýÁ¦¼úÀ» ½ÃÇàÇÑ ÈÄ ÃßÀû CT
¿µ»ç¿¡¼­ ´ã°üÀÇ È®Àå ºóµµ¸¦ µÎ °¡Áö ¹æ¹ý Áï, À§ °øÀå ¹®ÇÕ¼ú°ú À§ ½ÊÀÌÁöÀå ¹®ÇÕ¼ú¿¡¼­
ÀÇ Â÷ÀÌÁ¡°ú, ÀÓ»óÀû ¼Ò°ßÀ» ºñ±³ ºÐ¼®ÇÏ°íÀÚ º» ¿¬±¸¸¦ ÇÏ¿´´Ù.
´ë»ó ¹× ¹æ¹ý : À§¾ÏÀ¸·Î À§ ºÎºÐ ÀýÁ¦¼úÀ» ¹ÞÀº ȯÀÚ Áß ¼ö¼ú Àü º¹ºÎCT¿¡¼­ ´ã°ü È®Àå
¼Ò°ßÀÌ ¾ø¾úÀ¸¸ç ÃßÀû º¹ºÎ CT¿¡¼­ ´ã°ü È®ÀåÀ» º¸À̳ª ÀÓ»ó ¹× °Ë»ç½Ç ¼Ò°ß°ú ¹æ»ç¼±ÇÐÀû
À¸·Î ±â°èÀû ´ã°ü Æó¼â¸¦ ÀǽÉÇÒ ¸¸ÇÑ ¿øÀÎÀÌ º¸ÀÌÁö ¾Ê¾Ò´ø ȯÀÚ 113¸íÀ» ´ë»óÀ¸·Î ÃßÀû
º¹ºÎ CT¸¦ ÈÄÇâÀûÀ¸·Î ºÐ¼®ÇÏ¿´´Ù. ÀÌµé ¸ðµç ȯÀÚ´Â ´ã°ü ȯÀåÀº ¸»ÃÊ È¤Àº Á᫐ °£³»´ã
°ü ¹× °£¿Ü´ã°ü È®Àå Áß Çϳª ÀÌ»ó È®ÀåÀÌ º¸ÀÏ ¶§·Î Á¤ÀÇÇÏ¿´°í ´ã°üÀÇ È®ÀåÁ¤µµ´Â Áß½É
°£³»´ã°üÀÇ Á÷°æÀ» °èÃøÇÏ¿© °æ¹ÌÇÑ È®Àå(3-4§®), Áߵ È®Àå(5-8§®) ±×¸®°í ½ÉÇÑ È®Àå(9§®
ÀÌ»ó)À¸·Î ±¸ºÐÇÏ¿´°í °£¿Ü´ã°üÀº °æ¹ÌÇÑ È®Àå(6-8§®), Áߵ È®Àå(9-12§®)±×¸®°í ½ÉÇÑ È®
Àå(13§®ÀÌ»ó)À¸·Î ±¸ºÐÇÏ¿´´Ù. À§ ½ÊÀÌÁöÀå ¹®ÇÕ¼ú°ú À§ °øÀå ¹®ÇÕ¼úÀ» ½ÃÇàÇÑ µÎ ±ºÀ¸·Î
ºÐ·ùÇÏ¿© µÎ ±º¿¡¼­ÀÇ È®Àå ºóµµ ¹× Á¤µµ¿Í °Ë»ç½Ç ¼Ò°ßÀ¸·Î ÃÑ ºô¸®·çºó ¹× Á÷Á¢, °£Á¢ ºô
¸®·çºó(bilirubin)°ú ¾ËÄ«¶óÀÎ Æ÷½ºÆÄŸÁ¦(alkaline phosphatase)¸¦ ºñ±³ºÐ¼® ÇÏ¿´´Ù.
°á°ú : Àüü 113¸í Áß Á᫐ °£³»´ã°üÀÇ È®ÀåÀº 78¿¹(69%)¿¡¼­ ´ã°ü È®ÀåÀ» º¸À̸ç, À§ ½ÊÀÌ
ÁöÀå ¹®ÇÕ¼ú 41¿¹ Áß 24¿¹(58.4%), À§ °øÀå ¹®ÇÕ¼ú 72¿¹ Áß 54¿¹(75%)¿¡¼­ È®ÀåÀ» º¸¿© À§
°øÀå ¹®ÇÕ¼ú¿¡¼­ ¸¹Àº ºóµµ¸¦ º¸¿´À¸³ª µÎ ±º°£¿¡ Åë°èÇÐÀû »ó°ü°ü°è´Â ¾ø¾ú´Ù.( p>0.05)
µÎ ±ºÀÇ È®Àå Á¤µµ¸¦ ±¸ºÐÇÏ¿´À» ¶§ °æ¹ÌÇÑ È®ÀåÀº À§ ½ÊÀÌÁöÀå ¹®ÇÕ¼ú 41¿¹ Áß 15¿¹
(36.6%)¿Í À§ °øÀå ¹®ÇÕ¼ú 72¿¹ Áß 26¿¹(36.1%)¸¦ º¸À̸ç, Áߵ È®ÀåÀº °¢°¢ 7¿¹(17%),
25¿¹(34.7%) ±×¸®°í ½ÉÇÑ È®ÀåÀº °¢°¢ 2¿¹(4.8%), 3¿¹(4.2%)¿´À¸¸ç µÎ ±º »çÀÌ¿¡ Åë°èÀûÀÎ
»ó°ü °ü°è´Â ¾ø¾ú´Ù. ±×¸®°í °£¿Ü´ã°ü¿¡¼­µµ È®ÀåÀ» º¸ÀÎ °æ¿ì´Â Àüü 113¸í Áß 76¿¹(67%)
¿¡¼­ ´ã°üÈ®ÀåÀÌ ÀÖ¾úÀ¸¸ç À§ ½ÊÀÌÁöÀå ¹®ÇÕ¼ú¿¡¼­ 72¿¹ Áß 54¿¹(75%), À§ °øÀå ¹®ÇÕ¼ú¿¡¼­
´Â 41¿¹ Áß 22¿¹(53.6%)¸¦ º¸¿´´Ù. °Ë»ç½Ç ¼Ò°ßÀ¸·Î ÃÑ ºô¸®·çºóÀÇ Æò±ÕÀº À§ ½ÊÀÌÁöÀå ¹®
ÇÕ¼úÀ» ½ÃÇàÇÑ ±×·ì¿¡¼­ 0.711U/L, À§ °øÀå ¹®ÇÕ¼úÀ» ½ÃÇàÇÑ ±×·ì¿¡¼­ 0.83IU/L À̾úÀ¸¸ç,
Á÷Á¢ ºô¸®·çºóÀº °¢°¢ 0.16IU/L, 0.17IU/L, °£Á¢ ºô¸®·çºóÀº °¢°¢ 0.54IU/L, 0.64IU/LÀ̾ú°í,
¾ËÄ«¶óÀÎ Æ÷½ºÆÄŸÁ¦´Â °¢°¢ 73IU/L, 91 IU/L·Î ¸ðµÎ À§ °øÀå ¹®ÇÕ¼úÀ» ½ÃÇàÇÑ ±º¿¡¼­ ³ô
°Ô ³ª¿Ô°í Åë°èÇÐÀûÀ¸·Î ÀÇÀÇ´Â ÀÖ¾úÀ¸³ª ¸ðµÎ Á¤»ó¹üÀ§¿¡ µé¾î ÀÓ»óÀûÀ¸·Î ÀÇÀÇ´Â ¾ø¾ú´Ù.
°á ·Ð : À§ ºÎºÐ ÀýÁ¦¼ú ¹× ¹®ÇÕ¼úÀ» ½ÃÇàÇÑ È¯ÀÚ¿¡¼­ ´ã°ü È®ÀåÀº ÈçÈ÷ º¼ ¼ö ÀÖ´Â ¼Ò°ßÀÌ
°í ´ëºÎºÐ °æ¹ÌÇÑ È®ÀåÀ» º¸ÀÌ°í ÀÖÀ¸¸ç ÀÌ´Â ¼ö¼ú¹æ¹ý°ú´Â ¹«°üÇÏ¿´´Ù. ¶ÇÇÑ °Ë»ç½Ç ¼Ò°ß
µµ ¸ðµÎ Á¤»ó ¼öÄ¡¸¦ º¸ÀÌ°í ÀÖ¾ú´Ù. ±×·¯¹Ç·Î ¼ö¼ú ÈÄ ´ã°ü È®ÀåÀÌ º¸ÀÌ´õ¶óµµ ÀÓ»óÁõ»ó
ÀÌ ¾ø´Ù¸é ¿øÀÎÀ» ãÀ¸·Á´Â ´õ ÀÌ»óÀÇ °Ë»ç´Â ºÒÇÊ¿äÇÑ °ÍÀ¸·Î »ý°¢ÇÑ´Ù.
#ÃÊ·Ï#
Purpose : To evaluated the incidence and degree of bile duct dilatation after partial
gastrectomy due to gastric cancer and to determine any differences between
gastroduodenostomy (Billoth ¥°) and gastrojejunostomy (Billoth ¥±)
Materials and Methods : We retrospectively analyzed the follow up abdominal CT
findings in 113 patients who had undergone partial gastrectomy without truncal
vagotomy or cholecystectomy. In all cases, preoperative abdominal CT findings showed
no evidence of bile duct dilatation. Among 113 patients, 41 underwent billoth I surgery,
and 72 underwent Billoth ¥±. No case showed clinical or radiological evidence of
obstructive causes of bile duct dilatation. Among these patients, we decided the criteria
for dilatation when this was noted. The grade was either mild (3-4§®), moderate (5-8
§®), or severe (over 9§®), as measured at the central intra-hepatic duct. Extra-hepatic
duct dilatation was graded as mild (6-8§®), moderate(9-12§®) or severe (over 13§®). We
analyzed serum bilrirubin and alkaline phosphatase levels.
Results : When the central intrahepatic duct was measured, 78 of 113 patients(69%)
showed bile duct dilatation; 24 of 41 cases(58.5%) were in the billoth ¥°group and 54 of
72(75%)were the in Billoth ¥± group. After measurement of the extra hepatic duct, 22 of
41 cases(53.6%) in the billoth I group and 54 of 72(75%) in the Billoth ¥± group were
found to be dilated. The results showed a slightly increased incidence of bile duct
dilatation in the Billoth, ¥± group but this was not statistically significant (p>0.05). In
the laboratory, total, direct, and indirect bilirubin, as well as alkaline phosphatase levels,
were measured. Higher levels were found in Billoth ¥± than in Billoth I but all findings
were within normal limits.
Conclusion : Mild dilatation of the bile duct after partial gastrectomy was a not
uncommon finding, and there wes no significant difference of incidence or degree of
dilatation according to the procedure performed. If a patient has no clinical symptoms, it
appears that clinical it appears that clinical evaluation does not require further study.

Å°¿öµå

Bile ducts dilatation; Bile ducts CT; Stomach surgery;

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

µîÀçÀú³Î Á¤º¸

KoreaMed
KAMS